BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Oxford Immunotec Announces Launch of the AccutixTM Brand

  Oxford Immunotec Global PLC (Nasdaq:OXFD),today announced the launch of the Accutix brand for its tick-borne disease offering.

  May 22, 2018

   · 

  3 min read
• 

  Business

  Allergan Draws on Another Aptinyx Compound to Complement its Phase III Depression Drug

  Allergan has exercised an option to acquire an oral small molecule compound from Illinois-based Aptinyx, a spinout of Naurex, Inc., which the Irish company acquired in 2015. The company will use it as a complement to a Phase III depression treatment.

  May 22, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  One Last Chance: What to Do Before Quitting Your Job!

  Are you fantasizing about quitting your job? It can be difficult to stay focused and productive if you’re in a negative or toxic work environment.

  May 22, 2018

   · 

  4 min read

   · 

  Porschia Parker
• 

  BioCapital

  Educational Institutions Highlight Biotech Through Partnerships and Programs

  Educational institutions, even at the high school level, are creating specialized biotechnology training programs to satisfy the growth they see within the biotech industry.

  May 22, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Biotech CEO’s Wild Stunt and Death Shines Light on Community of Biohackers

  The mysterious death of a biotech startup chief executive officer in late April projected the term biohacker into the forefront of the industry lexicon.

  May 22, 2018

   · 

  3 min read

   · 

  Alex Keown
• BioMidwest

  Model Estimates Lifetime Risk Of Alzheimer’s Dementia Using Biomarkers For Preclinical Disease

  Study finds lifetime risk of developing Alzheimer’s varies by age, gender; First estimates that include biomarkers.

  May 22, 2018

   · 

  5 min read
• Nobles Medical Technologies II Showcases Noblestitch™ PFO Closure At EuroPCR

  NOBLES MEDICAL TECHNOLOGIES II, INC. (NMT2) ANNOUNCES THE PRESENTATION OF ITS ITALIAN CLINICAL DATA PUBLISHED IN EUROINTERVENTION TO BE PRESENTED BY DR. FREDERICO DEMARCO

  May 22, 2018

   · 

  5 min read
• Kansai University research: Kansai University Medical Polymers

  Kansai University launches the Smart Materials for Advanced and Reliable Therapeutics (KU-SMART) Project.

  May 22, 2018

   · 

  3 min read
• Drug Development

  uniQure Presents New Data Demonstrating Clinical Benefit in Hemophilia B Patients with Pre-Existing Anti-AAV5 Neutralizing Antibodies

  uniQure N.V. presented data showing successful liver transduction with the AAV5 vector in both non-human primates and humans with pre-existing anti-AAV5 neutralizing antibodies (NABs).

  May 22, 2018

   · 

  6 min read
• Business

  Cytox Launches Collaboration Agreement with Mayo Clinic to Evaluate Novel Genetic Based Approaches for Assessing Alzheimer’s Risk

  Important research collaboration for pioneering PRS approach

  May 22, 2018

   · 

  2 min read